What Can We Learn from COVID-19 Drug Development and Access for Non-Pandemic Diseases? A Chinese Perspective

Authors :: Zhenxiang Zhang
Yongguang Yang
Yuming Wang
Zhiping Guo
Hui Zhang
Lijun Shen
Source :: The American Journal of Bioethics. 21:42-45
Publication Year :: 2021
Publisher :: Informa UK Limited, 2021.
Abstract: The target article by Lynch et al. (2021) offers approaches for improving trial availability and Expanded Access for non-pandemic diseases based on the analysis of the COVID-19 experience in the US...

Subjects :: 2019-20 coronavirus outbreak
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
business.industry
Health Policy
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Perspective (graphical)
MEDLINE
Issues, ethics and legal aspects
Drug development
Expanded access
Family medicine
Pandemic
Medicine
business

Tools